key: cord-0918095-y0doer8x
authors: Schoening, V.; Liakoni, E.; Drewe, J.; Hammann, F.
title: Automatic identification of risk factors for SARS-CoV-2 positivity and severe clinical outcomes of COVID-19 using Data Mining and Natural Language Processing
date: 2021-03-26
journal: nan
DOI: 10.1101/2021.03.25.21254314
sha: ea3efbc58ee344af419fcf97419370003003de54
doc_id: 918095
cord_uid: y0doer8x

Objectives: Several risk factors have been identified for severe clinical outcomes of COVID-19 caused by SARS-CoV-2. Some can be found in structured data of patients' Electronic Health Records. Others are included as unstructured free-text, and thus cannot be easily detected automatically. We propose an automated real-time detection of risk factors using a combination of data mining and Natural Language Processing (NLP). Material and methods: Patients were categorized as negative or positive for SARS-CoV-2, and according to disease severity (severe or non-severe COVID-19). Comorbidities were identified in the unstructured free-text using NLP. Further risk factors were taken from the structured data. Results: 6250 patients were analysed (5664 negative and 586 positive; 461 non-severe and 125 severe). Using NLP, comorbidities, i.e. cardiovascular and pulmonary conditions, diabetes, dementia and cancer, were automatically detected (error rate [≤]2%). Old age, male sex, higher BMI, arterial hypertension, chronic heart failure, coronary heart disease, COPD, diabetes, insulin only treatment of diabetic patients, reduced kidney and liver function were risk factors for severe COVID-19. Interestingly, the proportion of diabetic patients using metformin but not insulin was significantly higher in the non-severe COVID-19 cohort (p<0.05). Discussion and conclusion: Our findings were in line with previously reported risk factors for severe COVID-19. NLP in combination with other data mining approaches appears to be a suitable tool for the automated real-time detection of risk factors, which can be a time saving support for risk assessment and triage, especially in patients with long medical histories and multiple comorbidities.

might not be included separately in the list of diagnoses (e.g. pre-diabetes). 67

Encoding into ICD (International Classification of Diseases) identifiers -which 68 would be highly suitable for machine processing -is often performed only after 69 discharge or death of the patient and is thus not readily available for the risk 70 evaluation on admission, requires human intervention, and might also only 71 include the main diagnoses relevant to billing purposes. 72

Here we propose a real-time support for patient triage by automatically 73 identifying relevant risk factors for infection with SARS-CoV-2 and for the 74 development of severe COVID-19 (i.e. need for critical care, mechanical 75 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 26, 2021. ; https://doi.org/10.1101/2021.03.25.21254314 doi: medRxiv preprint ventilation support, or death of any cause). A combination of data mining and 76 natural language processing (NLP) was used to analyse different parts of the 77 EHRs. Structured (tabulated) administrative, demographic and laboratory data 78 as well as unstructured (free-text) medical history information were processed 79 to identify specific risk factors (age, sex, high BMI, diabetes, cardiovascular 80 disease, pulmonary disorders, dementia, cancer, and decreased kidney and 81 liver function) for SARS-CoV-2 infection or severe courses of COVID-19. The study was carried out at the IHG. The protocol was approved by the 94 Cantonal Ethics Committee of Bern (Project-ID 2020-00973). We considered 95 all individuals tested for SARS-CoV-2 at the IHG between February 1 st through 96

November 16 th 2020-covering the 'first wave' and part of the 'second wave' of 97 COVID-19 in the country, and who did not reject the IHG general research 98 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) were also taken from the structured parts of the EHR. We used the lowest and 140 highest values measured, respectively, in the time frame between three days 141 before and one day after the Sars-CoV-2 test as described in a previous 142 study.(23) Kidney function was categorized into five stages: normal 143 (GFR ≥ 90 mL/min), mild impairment (GFR 60-89 mL/min), moderate 144 impairment (GFR 30-59 mL/min), severe impairment (GFR 15-29 mL/min) and 145 kidney failure (GFR < 15 mL/min).(24) Liver function was considered as 146 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The comorbidities of interest were identified in the medical history, which is the 149 unstructured, free-text part of the EHR. In a first step, we merged the 150 information of different time points into a single text file per patient and removed 151 duplicate sentences. We then read the text files into Python as data corpus, 152

where we performed the actual NLP ( Figure 2) . General data cleaning of these 153 files consisted of converting special characters (e.g. umlauts such as 'ä' to 'ae'), 154 setting the whole text to lower case, and removing dates. Then sentences were 155 tokenized, i.e. the text was separated into single (half-) sentences (tokens). 156

Tokens with less than two characters or information related to family history 157 were removed. As the medical history consisted mainly of catch phrases and 158 half-sentences, we decided against a removal of stop words. For each disease, 159 a specific list of key terms was generated, which consisted of common terms 160 (one or more words) and abbreviations used to describe the diseases in 161 German EHR systems. As there are many different terms for the diverse types 162 of cancer, another approach was chosen for this element. We first scanned all 163

EHRs for words containing cancer-specific terms such as 'cancer', 'carcinoma ', 164 or 'neoplasia', and created a key terms list. This list was then appended with 165 other common terms and abbreviations for specific types of cancer, for instance 166 'ALL' for acute lymphoblastic leukaemia. For correction of spelling errors and 167 lemmatization, the key terms list was transformed into a dictionary, where each 168 word only appears once. Words within the medical history were replaced with 169 the corresponding word of the dictionary when the similarity threshold of the 170 Levenshtein distance (minimum number of characters required to transform 171 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 26, 2021. ; https://doi.org/10.1101/2021.03.25.21254314 doi: medRxiv preprint one word to another) was equal or bigger than 90%. Then, for each token within 172 the medical history, we checked for the presence of the defined key terms. If 173

the key term consisted of more than one word (e.g. 'arterial hypertension'), the 174 algorithm was set to allow up to three words between the single words of the 175 key term. This further reduced the need for removing stop words. 176

If the key term was present, we determined the context of the key term 177 (affirmation or negation) using a German implementation of NegEx.(25) The 178 output of the negation detection was screened, and the negation trigger list 179 appended accordingly where necessary (e.g. 'non-insulin'). In case of an equal 180 or bigger number of affirmed than negated statements, the patient was tagged 181 as 'positive' for the disease. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. using Wilcoxon rank sum test for non-normally distributed parameters, as 220 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

A total of 6'250 patients tested for SARS-CoV-2 at the IHG during the study 225 period were included and categorized as either SARS-CoV-2 negative 226 (n=5'664) or positive (n=586), and -among the latter-as having a non-severe 227 (n=461) or severe (n=125) clinical outcome. The comorbidities of interest, i.e. 228 arterial hypertension, chronic heart failure, atrial fibrillation or flutter, coronary 229 heart disease, asthma, COPD, diabetes, dementia and cancer, could be 230 automatically detected in the German EHR of the IHG using NLP with an error 231 rate of ≤ 2% compared to the manually tagged EHR. The results of the 232 validation and the key terms used for each disease are shown in the 233 supplementary material (Table S1 and Table S2) . 234

Stratification of patients to the outcome showed that the proportions of patients 235 with old age, male sex, higher BMI, arterial hypertension, or diabetes were 236 significantly higher in the positive SARS-CoV-2 and in the severe COVID-19 237 cohorts ( Table 1) . Patients with atrial fibrillation or flutter were more likely to be 238 tested negative for SARS-CoV-2, but despite a tendency for more severe 239 clinical manifestations of COVID-19, these results were not significant. The 240 same proportion of patients with coronary heart disease was tested negative 241 and positive for SARS-CoV-2, but with a higher proportion of patients with a 242 severe course. 243 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Patients suffering from chronic heart failure or COPD were less likely to be 251 tested positive for SARS-CoV-2, but more likely to develop a severe COVID-19 252 course. In contract, significantly more asthmatic patients were tested positive 253 for SARS-CoV-2 than negative. However, with regards to clinical manifestation, 254 no difference could be observed between the two groups. Cancer patients were 255 less likely to be tested positive for SARS-CoV-2, but no significant difference in 256 severity was observed. 257 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Monotherapy of diabetes before admission in COVID-19 patients with insulin 301 was associated with a higher percentage of severe outcomes (29.6% vs. 9.0%). 302

By contrast, OAD treatment that included metformin was associated with a 303 higher percentage of non-severe disease progression (18.9% vs. 4.6%). This 304 decrease in severity was significant for the metformin group (p < 0.02). OAD 305 treatment that did not include metformin was not significantly associated with 306 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Our study has several limitations. As the IHG is a major hospital centre in the 334 region, patients admitted to the hospital for other reasons were also tested for 335 SARS-CoV-2 if they displayed any symptoms indicative for COVID-19. The 336 patients in the SARS-CoV-2 negative cohort probably have more health-related 337 problems than the general population. This effect is further corroborated as we 338 only analysed patients with available EHRs, and, due to the retrospective 339 nature of the study, had no information on patients tested at the ambulant 340 COVID-19 test centre without being admitted to the IHG as in-or out-patients. 341

This was partially mitigated by including records from the three months 342 preceding diagnosis. Therefore the higher incidence of specific comorbidities in 343 the SARS-CoV-2 negative cohort might represent a selection bias. Additionally, 344

we did not perform a case-controlled study or adjusted for cofounding factors 345 such as smoking or age. Furthermore, with the exception of diabetes and renal 346 function, we did no differentiate between the different stages and severities of 347 the diseases. This issue can be addressed by refining the key terms list in a 348 subsequent study. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 26, 2021. ; https://doi.org/10.1101/2021.03.25.21254314 doi: medRxiv preprint

Obesity: A critical risk factor in the COVID-19 409 pandemic. Clinical obesity

Obesity is a risk factor for developing critical 411 condition in COVID-19 patients: A systematic review and meta-analysis. 412 Obesity reviews : an official journal of the International Association for the Study 413 of Obesity

Obesity Is a Risk Factor for Severe 415 COVID-19 Infection: Multiple Potential Mechanisms. Circulation

Association of Blood Glucose Control and 418 Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell 419 metabolism

The influence of diabetes and hypertension on outcome 421 in COVID-19 patients: Do we mix apples and oranges? The Journal of Clinical 422 Hypertension

COVID-19 and diabetes mellitus: from 424 pathophysiology to clinical management

Cardiovascular Disease, 427 Drug Therapy, and Mortality in Covid-19

430 Association of cardiovascular disease and 10 other pre-existing comorbidities 431 with COVID-19 mortality: A systematic review and meta-analysis

Characteristics and outcomes of 434 patients hospitalized for COVID-19 and cardiac disease in Northern Italy

Prevalence of comorbidities and its effects 437 in patients infected with SARS-CoV-2: a systematic review and meta-analysis

COVID-19 Susceptibility in chronic obstructive pulmonary 440 disease

Use of Real-World Electronic Health 443 Records to Estimate Risk, Risk Factors, and Disparities for COVID-19 in 444 Patients With Cancer

COVID-19 and dementia: Analyses 446 of risk, disparity, and outcomes from electronic health records in the US

Alzheimer's & Dementia

Coronavirus disease (COVID-19): A 449 systematic review and meta-analysis to evaluate the impact of various 450 comorbidities on serious events

24 National Kidney Foundation. K/DOQI clinical practice guidelines for chronic 460 kidney disease: evaluation, classification, and stratification

Negation 463 Detection in Clinical Reports Written in German

Natural Language Processing with Python: O'Reilly 465 Media

A 467 Simple Algorithm for Identifying Negated Findings and Diseases in Discharge 468 Summaries

Clinical Text Mining: Secondary Use of Electronic Patient 470 Records: Springer Nature

Risk factors for Covid-19 severity 472 and fatality: a structured literature review

The Age-Related 474 Risk of Severe Outcomes Due to COVID-19 Infection: A Rapid Review

Sex differences in immune 478 responses that underlie COVID-19 disease outcomes

Gender differences in the battle 481 against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle 482 on differences in outcomes

Comorbidity and its impact on 1590 485 patients with Covid-19 in China: A Nationwide Analysis

Covid-19 in Critically Ill 488 Patients in the Seattle Region -Case Series

Characteristics and Outcomes of 21 Critically 491 Ill Patients With COVID-19 in Washington State

Predictors of adverse in-hospital outcome and recovery in patients with 494 diabetes mellitus and COVID-19 pneumonia in Iraq

Metformin is Associated with Decreased 30-Day Mortality Among Nursing 498 Home Residents Infected with SARS-CoV2

Mortality risk with preadmission metformin use in 501 patients with COVID-19 and diabetes: A meta-analysis

AMP-activated protein kinase: 504 ancient energy gauge provides clues to modern understanding of metabolism

Effect of 507 common medications on the expression of SARS-CoV-2 entry receptors in liver 508 tissue

The dual impact of ACE2 in COVID-19 and 510 ironical actions in geriatrics and pediatrics with possible therapeutic solutions

Physiological and pathological regulation of 513 ACE2, the SARS-CoV-2 receptor

Trilogy of ACE2: a 515 peptidase in the renin-angiotensin system, a SARS receptor, and a partner for 516 amino acid transporters

Angiotensin-converting enzyme 2 protects from 518 severe acute lung failure

Role of angiotensin-converting enzyme 2 520 (ACE2) in COVID-19. Critical Care

mTOR inhibition in COVID-19: A 522 commentary and review of efficacy in RNA viruses

Antiviral Activity of Metformin and Its Potential Implications in Treating 526 Coronavirus Disease 2019 and Lung Injury

Chronic obstructive pulmonary 528 disease and the COVID-19 pandemic: Reciprocal challenges

Nicotine 531 and smoking in the COVID-19 era

Systematic review of the prevalence of 534 current smoking among hospitalized COVID-19 patients in China: could 535 nicotine be a therapeutic option? Internal and emergency medicine

Risk of COVID-19-related death 538 among patients with chronic obstructive pulmonary disease or asthma 539 prescribed inhaled corticosteroids: an observational cohort study using the 540 OpenSAFELY platform. The Lancet Respiratory Medicine